ScoreWhy is Eiko Lifesciences Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 2.67%
2
With a growth in Net Sales of 124.26%, the company declared Very Positive results in Mar 26
- The company has declared positive results for the last 4 consecutive quarters
- NET SALES(Q) At Rs 18.34 cr has Grown at 62.73%
- PBDIT(Q) Highest at Rs 2.28 cr.
- PBT LESS OI(Q) Highest at Rs 1.89 cr.
3
With ROE of 6.5, it has a Very Attractive valuation with a 1.1 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 0.41%, its profits have risen by 142% ; the PEG ratio of the company is 0.2
4
Majority shareholders : Non Institution
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Eiko Lifescience should be less than 10%
- Overall Portfolio exposure to Specialty Chemicals should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Eiko Lifescience for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Eiko Lifescience
0.41%
0.01
46.87%
Sensex
-10.21%
-0.78
13.06%
Management Risk
Growth
Capital StructureValuationValuation Key Factors 
Factor
Value
P/E Ratio
16
Industry P/E
20
Price to Book Value
1.07
EV to EBIT
10.13
EV to EBITDA
8.74
EV to Capital Employed
1.09
EV to Sales
1.23
PEG Ratio
0.15
Dividend Yield
NA
ROCE (Latest)
10.72%
ROE (Latest)
6.54%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend26What is working for the Company
NET SALES(Q)
At Rs 18.34 cr has Grown at 62.73%
PBDIT(Q)
Highest at Rs 2.28 cr.
PBT LESS OI(Q)
Highest at Rs 1.89 cr.
PAT(Q)
Highest at Rs 1.30 cr.
EPS(Q)
Highest at Rs 0.91
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Eiko Lifescience
Net Sales - Quarterly
At Rs 18.34 cr has Grown at 62.73%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 2.28 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 1.89 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 1.30 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 18.34 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 0.91
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
